Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Necrosis Pattern of Acute Renal Failure

NCT07161843 is registered in ClinicalTrials.gov with Ebima Clifford Okundaye as lead sponsor.

NCT NCT07161843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07161843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determine the Efficacy of Investigational Drug QRX-3 in Hospitalized Patients With Acute Tubular Necrosis Pattern of Acute Renal Failure
Lead sponsor
Ebima Clifford Okundaye
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
February 1, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure (arf), acute tubular necrosis